News on MorphoSys AG from BioPortfolio.com http://www.BioPortfolio.com Consolidated MorphoSys AG news from BioPortfolio.com Tue, 09 Feb 2010 18:13:07 GMT en MorphoSys and WACKER Expand Cooperation to Use WACKER's ESETEC Technologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019565&HITNO=0&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019565&THISHREF=http://c.moreover.com/click/here.pl%3fz2526372125%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019565&HITNO=0&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019565&THISHREF=http://c.moreover.com/click/here.pl%3fz2526372125%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCombiChemnet: Shionogi & Co expands research license to use MorphoSys HuCAL PLATINUMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990292&HITNO=1&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990292&THISHREF=http://c.moreover.com/click/here.pl%3fz2513250378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990292&HITNO=1&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990292&THISHREF=http://c.moreover.com/click/here.pl%3fz2513250378%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: MorphoSys AG (DE) - MorphoSys Licenses HuCAL PLATINUM Antibody Library to Shionogi in Research Partnershiphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972528&HITNO=2&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972528&THISHREF=http://c.moreover.com/click/here.pl%3fz2502451662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3972528&HITNO=2&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3972528&THISHREF=http://c.moreover.com/click/here.pl%3fz2502451662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: MorphoSys Licenses HuCAL PLATINUM(R) Antibody Library to Shionogi in Research Partnershiphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967944&HITNO=3&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967944&THISHREF=http://c.moreover.com/click/here.pl%3fz2500036467%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967944&HITNO=3&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967944&THISHREF=http://c.moreover.com/click/here.pl%3fz2500036467%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Week Of Jan. 25, 2010: Company And People Notes: Novartis CEO To Step Down; DSM To Close Netherlands Facility; And More.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968085&HITNO=4&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968085&THISHREF=http://c.moreover.com/click/here.pl%3fz2500136098%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968085&HITNO=4&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968085&THISHREF=http://c.moreover.com/click/here.pl%3fz2500136098%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: MorphoSys licenses HuCAL PLATINUM Antibody Library to Shionogihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968818&HITNO=5&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968818&THISHREF=http://c.moreover.com/click/here.pl%3fz2500554068%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968818&HITNO=5&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968818&THISHREF=http://c.moreover.com/click/here.pl%3fz2500554068%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Shionogi Expands Research Partnership With MorphoSyshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968360&HITNO=6&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968360&THISHREF=http://c.moreover.com/click/here.pl%3fz2500323662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968360&HITNO=6&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968360&THISHREF=http://c.moreover.com/click/here.pl%3fz2500323662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Business Review: German Morphosys grants antibody library licence to Japan's Shionogihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970395&HITNO=7&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970395&THISHREF=http://c.moreover.com/click/here.pl%3fz2501310540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970395&HITNO=7&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970395&THISHREF=http://c.moreover.com/click/here.pl%3fz2501310540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comADP News: Shionogi Licenses MorphoSys HuCAL Platinum Antibody Libraryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970936&HITNO=8&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970936&THISHREF=http://c.moreover.com/click/here.pl%3fz2501567055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970936&HITNO=8&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970936&THISHREF=http://c.moreover.com/click/here.pl%3fz2501567055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Wacker and MorphoSys expand Cooperation to use Wacker's ESETEC Technology for Production of Antigen Materialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954378&HITNO=9&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954378&THISHREF=http://c.moreover.com/click/here.pl%3fz2492671084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954378&HITNO=9&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954378&THISHREF=http://c.moreover.com/click/here.pl%3fz2492671084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: MorphoSys to use Wacker's bacterial secretion technology ESETEC for production of antigen materialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948377&HITNO=10&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948377&THISHREF=http://c.moreover.com/click/here.pl%3fz2488543920%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948377&HITNO=10&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948377&THISHREF=http://c.moreover.com/click/here.pl%3fz2488543920%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: MorphoSys AG Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 Program in Rheumatoid Arthritishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950085&HITNO=11&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950085&THISHREF=http://c.moreover.com/click/here.pl%3fz2489459038%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950085&HITNO=11&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950085&THISHREF=http://c.moreover.com/click/here.pl%3fz2489459038%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 Program in Rheumatoid Arthritishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949173&HITNO=12&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949173&THISHREF=http://c.moreover.com/click/here.pl%3fz2488963954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949173&HITNO=12&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949173&THISHREF=http://c.moreover.com/click/here.pl%3fz2488963954%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 Program in Rheumatoid Arthritishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945673&HITNO=13&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945673&THISHREF=http://c.moreover.com/click/here.pl%3fz2487254800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945673&HITNO=13&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945673&THISHREF=http://c.moreover.com/click/here.pl%3fz2487254800%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCombiChemnet: Wacker, Morphosys Expand Antigen Technology Pacthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3938518&HITNO=14&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3938518&THISHREF=http://c.moreover.com/click/here.pl%3fz2484026611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3938518&HITNO=14&MSIZE=55&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MorphoSys%20AG&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3938518&THISHREF=http://c.moreover.com/click/here.pl%3fz2484026611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comContract Pharma: